Jia‐Ning Xiang

908 citations

21 papers · 545 indexed · h-index 14

Co-authors: John D. Elliott Yusheng Wu Marlys Hammond Philip M. Harrington Andrew G. Myers Elaine Y. Kuo Xichen Lin Feng Ren
Topics: Nitric Oxide and Endothelin Effects (4 papers)Sphingolipid Metabolism and Signaling (4 papers)Lipid Membrane Structure and Behavior (3 papers)
Cited by: Organic Chemistry Immunology Oncology
Journals: Journal of the American Chemical Society Advanced Drug Delivery Reviews Journal of Medicinal Chemistry
Partner nations: China United States United Kingdom

In The Last Decade

Jia‐Ning Xiang

21 papers receiving 526 citations

Peers

Countries citing papers authored by Jia‐Ning Xiang

Since Specialization

Citations

This map shows the geographic impact of Jia‐Ning Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia‐Ning Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia‐Ning Xiang more than expected).

Fields of papers citing papers by Jia‐Ning Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia‐Ning Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia‐Ning Xiang. The network helps show where Jia‐Ning Xiang may publish in the future.

Co-authorship network of co-authors of Jia‐Ning Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jia‐Ning Xiang. A scholar is included among the top collaborators of Jia‐Ning Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia‐Ning Xiang. Jia‐Ning Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	501 Clinical PK of XW10172 for Once Nightly Therapy in Patients with Narcolepsy or Sleep Disorders in Neurodegenerative Diseases 2021 ·SLEEP ·Daniel M. Canafax,(unknown),Jia‐Ning Xiang	3
2	Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists 2018 ·Journal of Medicinal Chemistry ·(unknown),Ting Yang,(unknown),Xichen Lin,Qian Ding,Yueting Zhang,Xin Cai,Kelly Dong,(unknown),Wei Zhang,(unknown),Royston C. B. Copley,Jia‐Ning Xiang,Xiao-Ming Guan,Paul Wren,Feng Ren	16
3	From RORγt Agonist to Two Types of RORγt Inverse Agonists 2018 ·ACS Medicinal Chemistry Letters ·Yonghui Wang,Wei Cai,Ting Tang,Qian Liu,Ting Yang,Liuqing Yang,Yingli Ma,Guifeng Zhang,Yafei Huang,Xiaoxia Song,Lisa A. Orband‐Miller,Qianqian Wu,Ling Zhou,Zhijun Xiang,Jia‐Ning Xiang,Stewart Leung,Liming Shao,Xichen Lin,Mercedes Lobera,Feng Ren	22
4	Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders 2016 ·ACS Medicinal Chemistry Letters ·Heng Xu,(unknown),(unknown),(unknown),Chengyong Li,Yan Xu,Kelly Dong,Jinqiang Zhang,Xiong Li,Yvonne Li,Gentao Liu,(unknown),Yonggang Zhao,Ailian Liu,Yueting Zhang,Wei Zhang,Xin Cai,Jia‐Ning Xiang,John D. Elliott,Xichen Lin	16
5	Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists 2015 ·Bioorganic & Medicinal Chemistry ·Yonghui Wang,Ting Yang,Qian Liu,Yingli Ma,Liuqing Yang,Ling Zhou,Zhijun Xiang,Ziqiang Cheng,Sijie Lu,Lisa A. Orband‐Miller,Wei Zhang,Qianqian Wu,(unknown),Yi Li,Jia‐Ning Xiang,John D. Elliott,Stewart Leung,Feng Ren,Xichen Lin	26
6	2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: Discovery of novel and potent CXCR2 antagonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Ting Yang,(unknown),Paul Wren,Yueting Zhang,Xin Cai,(unknown),Kelly Dong,Qing Zhang,Wei Zhang,Xiao-Ming Guan,Jia‐Ning Xiang,John D. Elliott,Xichen Lin,Feng Ren	11
7	Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·Guanghui Deng,Baowei Zhao,Yingli Ma,(unknown),Hailong Wang,Liuqing Yang,Qing Zhang,Taylor B. Guo,Wei Zhang,(unknown),Xin Cai,Jinqiang Zhang,Houfu Liu,Xiao-Ming Guan,Hongtao Lu,Jia‐Ning Xiang,John D. Elliott,Xichen Lin,Feng Ren	14
8	Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists 2013 ·ACS Medicinal Chemistry Letters ·Ting Yang,Qian Liu,(unknown),Wei Cai,Yingli Ma,Liuqing Yang,Qianqian Wu,Lisa A. Orband‐Miller,Ling Zhou,Zhijun Xiang,(unknown),Wei Zhang,Jing Zhang,Jia‐Ning Xiang,Stewart Leung,(unknown),Zhong Zhong,John D. Elliott,Xichen Lin,Yonghui Wang	56
9	A catalyst-free N–H insertion/Mannich-type reaction cascade of α-nitrodiazoesters 2013 ·Tetrahedron Letters ·Ting Yang,Hao Zhuang,Xichen Lin,Jia‐Ning Xiang,John D. Elliott,Lianghui Liu,Feng Ren	6
10	Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Baowei Zhao,(unknown),Xuesong Xu,Guanghui Deng,Chengyong Li,(unknown),Feng Ren,Hailong Wang,Heng Xu,Yan Xu,Haibo Zhang,Jia‐Ning Xiang,John D. Elliott,Taylor B. Guo,Yonggang Zhao,Wei Zhang,Hongtao Lu,Xichen Lin	14
11	Identification of benzoxazole analogs as novel, S1P3 sparing S1P1 agonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Guanghui Deng,(unknown),Qian Liu,Xuesong Xu,(unknown),Feng Ren,Taylor B. Guo,Hongtao Lu,Jia‐Ning Xiang,John D. Elliott,Xichen Lin	7
12	Discovery of thiadiazole amides as potent, S1P3-sparing agonists of sphingosine-1-phosphate 1 (S1P1) receptor 2012 ·Bioorganic & Medicinal Chemistry Letters ·Heng Xu,Haibo Zhang,(unknown),Yan Xu,Chengyong Li,Yonghui Wang,(unknown),Ting Yang,Feng Ren,Jia‐Ning Xiang,John D. Elliott,Yonggang Zhao,Taylor B. Guo,Hongtao Lu,Wei Zhang,David J. Hirst,Matthew Lindon,Xichen Lin	3
13	Discovery of Novel 1,2,4-Thiadiazole Derivatives as Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P₁) 2012 ·Journal of Medicinal Chemistry ·Feng Ren,Guanghui Deng,Hailong Wang,(unknown),(unknown),(unknown),Heng Xu,Xuesong Xu,Haibo Zhang,Baowei Zhao,Chengyong Li,Taylor B. Guo,Jiansong Yang,Wei Zhang,Yonggang Zhao,(unknown),Hongtao Lu,Jia‐Ning Xiang,John D. Elliott,Xichen Lin	17
14	XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: I. Design, Synthesis, Enzymatic Conversion to Gabapentin, and Transport by Intestinal Solute Transporters 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Kenneth C. Cundy,(unknown),Tania Chernov-Rogan,(unknown),(unknown),Karin M. Höld,Kerry J. Koller,Xiaoli Liu,(unknown),(unknown),(unknown),(unknown),(unknown),Jia‐Ning Xiang,Hui Yan,Noa Zerangue,(unknown),Ronald W. Barrett,Mark A. Gallop	122
15	Development of an Enantioselective Synthetic Route to Neocarzinostatin Chromophore and Its Use for Multiple Radioisotopic Incorporation 2002 ·Journal of the American Chemical Society ·Andrew G. Myers,Ralf Glatthar,Marlys Hammond,Philip M. Harrington,Elaine Y. Kuo,Jun Liang,Scott E. Schaus,Yusheng Wu,Jia‐Ning Xiang	60
16	Pharmacologic Characterization of the Novel, Orally Available Endothelin-A-Selective Antagonist SB 247083 1998 ·Journal of Cardiovascular Pharmacology ·Stephen A. Douglas,Ponnal Nambi,Miklos Gellai,Juan I. Luengo,Jia‐Ning Xiang,David P. Brooks,Robert Ruffolo,John D. Elliott,Eliot H. Ohlstein	5
17	Plasma- and Cerebrospinal Fluid-Immunoreactive Endothelin-1: Effects of Nonpeptide Endothelin Receptor Antagonists with Diverse Affinity Profiles for Endothelin-A and Endothelin-B Receptors 1998 ·Journal of Cardiovascular Pharmacology ·Robert N. Willette,Charles F. Sauermelch,Barbara L. Storer,(unknown),Juan I. Luengo,Jia‐Ning Xiang,John D. Elliott,Eliot H. Ohlstein	18
18	An Efficient Approach to the Synthesis of 1,3-Diaryl-1,2,3,4-[4H]-tetrahydronaphthalene-2-carboxylic Acids 1998 ·Bioorganic & Medicinal Chemistry ·Jia‐Ning Xiang,Ponnal Nambi,Eliot H. Ohlstein,John D. Elliott	10
19	In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists 1997 ·Advanced Drug Delivery Reviews ·Harma Ellens,(unknown),Chao‐Pin Lee,(unknown),Amparo M. Lago,Jia‐Ning Xiang,John D. Elliott,Hung‐Yuan Cheng,Eliot H. Ohlstein,Philip L. Smith	13
20	Enantioselective Synthesis of Neocarzinostatin Chromophore Aglycon 1996 ·Journal of the American Chemical Society ·Andrew G. Myers,Marlys Hammond,Yusheng Wu,Jia‐Ning Xiang,Philip M. Harrington,Elaine Y. Kuo	47

About Jia‐Ning Xiang

Jia‐Ning Xiang is a scholar working on Physiology, Biochemistry and Endocrine and Autonomic Systems, having authored 21 papers that have together received 545 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (4 papers), Sphingolipid Metabolism and Signaling (4 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Organic Chemistry (194 citations), Immunology (107 citations) and Oncology (133 citations). Jia‐Ning Xiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include John D. Elliott, Yusheng Wu, Marlys Hammond, Philip M. Harrington, Andrew G. Myers, Elaine Y. Kuo, Xichen Lin, Feng Ren, Scott E. Schaus and Ralf Glatthar. Their work appears in journals such as Journal of the American Chemical Society, Advanced Drug Delivery Reviews and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact